Waldstein, Sebastian M <br/><br/>
Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.  [electronic resource] 

 -  Ophthalmology  07 2016 
 - 1521-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2016.03.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Angiogenesis Inhibitors--therapeutic use<br/>Choroidal Neovascularization--drug therapy<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ranibizumab--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Retina--pathology<br/>Tomography, Optical Coherence<br/>Visual Acuity--drug effects<br/>Wet Macular Degeneration--drug therapy